Expression of and role for ovarian cancer G-protein-coupled receptor 1 (OGR1) during osteoclastogenesis
Department of Cell Biology
Animals; Cell Differentiation; Cell Line; Cells, Cultured; Female; Macrophage Colony-Stimulating Factor; Mice; Neoplasm Proteins; Osteoclasts; Osteogenesis; Osteopetrosis; Ovarian Neoplasms; RNA, Messenger; Rats; Rats, Mutant Strains; Receptors, G-Protein-Coupled
Cell Biology | Life Sciences | Medicine and Health Sciences
Osteoclasts differentiate from hematopoietic mononuclear precursor cells under the control of both colony stimulating factor-1 (CSF-1, or M-CSF) and receptor activator of NF-kappaB ligand (RANKL, or TRANCE, TNFSF11) to carry out bone resorption. Using high density gene microarrays, we followed gene expression changes in long bone RNA when CSF-1 injections were used to restore osteoclast populations in the CSF-1-null toothless (csf1(tl)/csf1(tl)) osteopetrotic rat. We found that ovarian cancer G-protein-coupled receptor 1 (OGR1, or GPR68) was strongly up-regulated, rising >6-fold in vivo after 2 days of CSF-1 treatments. OGR1 is a dual membrane receptor for both protons (extracellular pH) and lysolipids. Strong induction of OGR1 mRNA was also observed by microarray, real-time RT-PCR, and immunoblotting when mouse bone marrow mononuclear cells and RAW 264.7 pre-osteoclast-like cells were treated with RANKL to induce osteoclast differentiation. Anti-OGR1 immunofluorescence showed intense labeling of RANKL-treated RAW cells. The time course of OGR1 mRNA expression suggests that OGR1 induction is early but not immediate, peaking 2 days after inducing osteoclast differentiation both in vivo and in vitro. Specific inhibition of OGR1 by anti-OGR1 antibody and by small inhibitory RNA inhibited RANKL-induced differentiation of both mouse bone marrow mononuclear cells and RAW cells in vitro, as evidenced by a decrease in tartrate-resistant acid phosphatase-positive osteoclasts. Taken together, these data indicate that OGR1 is expressed early during osteoclastogenesis both in vivo and in vitro and plays a role in osteoclast differentiation.
DOI of Published Version
J Biol Chem. 2006 Aug 18;281(33):23598-605. Epub 2006 Jun 19. Link to article on publisher's site
The Journal of biological chemistry
Yang, Meilheng; Mailhot, Genevieve; Birnbaum, Mark J.; MacKay, Carole A.; Mason-Savas, April; and Odgren, Paul R., "Expression of and role for ovarian cancer G-protein-coupled receptor 1 (OGR1) during osteoclastogenesis" (2006). Open Access Articles. 677.